- Home
- Reagents
- Overview
- Primary Antibodies
- Overview
- Anti-Allergen Antibodies
- Anti-Coronavirus Antibodies
- Anti-Virus Antibodies
- Antibodies to Epitope Tags
- DNA/RNA Research Antibodies
- Immunotherapy Research Antibodies
- Murine Bispecific Antibody Reagents
- Neuroscience Research Antibodies
- Recombinant Antibodies from Human Patients
- Recombinant Isotype Controls
- Research-Grade Biosimilars
- Tumor Marker Antigens
- VivopureX™ Antibodies for In Vivo Research
- Secondary Antibodies
- Recombinant Proteins
- Services
- Our Technology
- About Us
- Antibody Resource
- News & Events
- How to Order
58
Products in this category:
Antibody Name [Clone]
Expected Species Reactivity
Applications
-
Anti-A27L, Protein A27 [8E3]Vaccinia viruscrystallography, neutralization, ELISA, FC
-
Anti-Bordetella pertussis lipooligosaccharide [HBp2]Bordetella pertussisneutralization, RIA, WB, ELISA
-
Anti-Cap, Capsid protein [3A5]Porcine circovirus 2in vitro, neutralization, ELISA, IF, IHC
-
Anti-Capsid protein [A6.2]Murine norovirus 1in vitro, neutralization, ELISA
-
Anti-Cell surface-binding protein D8L [LA5]Vaccinia virusneutralization, SPR, ELISA
-
Anti-Dengue virus envelope protein [C9]Dengue Virusneutralization, ELISA, IF
-
Anti-Domain I of the DENV-4 envelope protein (E) [5H2]Dengue Virusneutralization, ELISA
-
Anti-Domain II of the DENV-2 envelope protein (E) [1A5]Dengue VirusIP, neutralization, WB, ELISA
-
Anti-E protein [13D6]Tick-borne encephalitis virusneutralization, ELISA, IHC
-
Anti-E protein [14D5]Tick-borne encephalitis viruscrystallization, in vitro, in vivo, neutralization, SPR, ELISA
-
Anti-Entry-fusion complex associated protein OPG095 [M12B9]Vaccinia virusin vivo, neutralization, ELISA, FC
-
Anti-env, Envelope glycoprotein gp160 [Fab 58.2]Human immunodeficiency virus type 1 group M subtype Bcrystallography, in vitro, neutralization, ELISA
-
Anti-env, Envelope glycoprotein gp160 [ITS090.03]Simian immunodeficiency viruscrystallography, in vitro, neutralization, ELISA
-
Anti-Envelope glycoprotein E2 [F5]Venezuelan equine encephalitis virusin vitro, in vivo, neutralization, ELISA, IHC
-
Anti-Envelope glycoprotein gp160 [0.5beta]Human immunodeficiency virus type 1 group M subtype Bneutralization, WB, ELISA
-
Anti-Envelopment polyprotein [RV-Gn3]Rift Valley fever viruscrystallography, neutralization, ELISA
-
Anti-F protein [mAb 234]Human metapneumovirus (hMPV)neutralization, ELISA
-
Anti-F protein [mAb 338]Human metapneumovirus (hMPV)neutralization, ELISA
-
Anti-Fusion glycoprotein F0 [17-HD9]Human respiratory syncytial virus Aneutralization, ELISA
-
Anti-Fusion glycoprotein F0 [B13]Bovine respiratory syncytial virus, Human respiratory syncytial virus Acrystallography, neutralization, SPR, ELISA, IHC
-
Anti-Gc [R5]Rift Valley fever virus, RVFVFACS, in vivo, neutralization, SPR, ELISA
-
Anti-Genome polyprotein [14B10]Coxsackievirus A16in vitro, neutralization, ELISA
-
Anti-Genome polyprotein [18A7]Coxsackievirus A16in vitro, neutralization, ELISA
-
Anti-Genome polyprotein [1D5]Coxsackievirus A6in vitro, in vivo, neutralization, ELISA, IHC
-
Anti-Genome polyprotein [3E31]Dengue virus type 4neutralization, ELISA
-
Anti-Genome polyprotein [AM28]Human parechovirusneutralization, SPR, ELISA, IF
-
Anti-Genome polyprotein [anti-CVA16-14B10]Coxsackievirus A16 (strain Tainan/5079/98)in vitro, neutralization, ELISA
-
Anti-Genome polyprotein [anti-CVA16-NA9D7]Coxsackievirus A16 (strain Tainan/5079/98)in vitro, neutralization, ELISA
-
Anti-Genome polyprotein [E106]Dengue Virusin vitro, in vivo, neutralization, SPR, ELISA, FC
-
Anti-Genome polyprotein [HC33.4]Hepatitis C virusneutralization, ELISA